Women with knee osteoarthritis (OA) experience more pain and inflammation than men, according to a new study led by researchers at Hospital for Special Surgery (HSS) and The Rockefeller University.
The study found that semaglutide, sold under brand names Ozempic and Wegovy reduced the hospitalization risk by 22% in alcoholic patients. Ozempic had earlier been shown to mitigate joint pain.